Selenium as marker for cancer risk and prevention

• Authors: Marcin Lener , Katarzyna Jaworska , Magdalena Muszyńska , Grzegorz Sukiennicki , Katarzyna Durda , Satish Gupta , Elżbieta Złowocka-Perłowska , Józef Kładny , Anna Wiechowska-Kozłowska , Tomasz Grodzki , Ewa Jaworowska , Jakub Lubiński , Barbara Górecka-Szyld , Grażyna Wilk , Mieczysław Sulikowski , Tomasz Huzarski , Tomasz Byrski , Cezary Cybulski , Jacek Gronwald , Tadeusz Dębniak , Olgierd Ashuryk , Aleksandra Tołoczko-Grabarek , Anna Jakubowska , Antoni Morawski , Jan Lubiński
• Languages of publication: EN
• Publisher: De Gruyter Open
• Journal: Polish Journal of Surgery
• Year: 2012
• Volume: 84
• Issue: 9
• Pages: 470-475

Dates

published

1 - 10 - 2012

online

23 - 10 - 2012

References

• 1. Combs GF, Clark LC , Turnbull BW: An analysis of cancer prevention by selenium. Biofactors 2001; 14: 153-59.[PubMed][Crossref]
• 2. Torun M, Aldemir H, Yardim S: Serum selenium levels in various cancer types. Trace Elem Electroly 1995; 12: 186-90.
• 3. Zachara B: Mammalian selenoproteins. J Trace Elem Electrol Health Dis 1992; 6: 137-51.
• 4. Zachara BA, Marchaluk-Wisniewska E, Maciąg A et al.: Decreased selenium concentration and glutathione peroxidase activity in blood and increase of these parameters in malignant tissue of lung cancer patients. Lung 1997; 175: 321-32.
• 5. Combs GF Jr: Selenium and cancer prevention. In: antioxidants and disease prevention. HS Garewal (red), CRC Press, Boca Raton, New York, 1997; s. 97-113.
• 6. Combs GF, Gray WP: Chemopreventive agents: selenium. Pharmacol Ther 1998; 79: 179-92.[Crossref][PubMed]
• 7. Jacques KA : Selenium metabolism in animals: the relationship between dietary selenium form and physiological response. Science and Technology in the Feed Industry. Proceedings of Alltech’s 17th Annual Symposium. Lyons TP and Jacques KA, Nottingham University Press. 2001; s. 319-48.
• 8. Schrauzer GN, White DA, Schneider CJ: Cancer mortality correlation studies III. Statistical association with dietary selenium intakes. Bioinorg Chem 1977; 7: 23-24.[Crossref]
• 9. van den Brandt PA, Goldbohm RA , van’t Veer P et al.: A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 1993; 53: 4860-65.
• 10. van den Brandt PA, Zeegers MP, Bode P et al.: Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2003;12: 866-71.
• 11. Zeegers MP, Goldbohm RA , Bode P et al.: Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 1292-97.
• 12. van den Brandt PA, Goldbohm RA , van’t Veer P et al.: A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. J Natl Cancer Inst 1993; 85: 224-29.
• 13. Steevens J, van den Brandt PA, Goldbohm RA et al.: Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenterology 2010; 138: 1704-13.[WoS]
• 14. Knekt P, Aromaa A, Maatela J et al.: Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990; 82: 864-68.[Crossref]
• 15. van den Brandt PA, Goldbohm RA , van’t Veer P et al.: Toenail selenium levels and the risk of breast cancer. Am J Epidemiol 1994; 140: 20-26.
• 16. Duffield-Lillico AJ, Reid ME , Turnbull BW et al.: Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002; 11: 630-39.
• 17. Lajtman Z, Nosso D, Romic Z et al.: Laryngeal cancer and blood selenium levels. Eur Arch Otorhinolaryngol 1994; 251: 170-72.
• 18. Clark LC , Combs GF Jr, Turnbull BW et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial. JAMA 1996; 276: 1957-63.
• 19. Reid ME , Duffield-Lillico AJ, Garland L et al.: Selenium supplementation and lung cancer incidence: An update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 2002; 11: 1285-91.
• 20. Menkes MS , Comstock GW, Vuilleumier JP et al.: Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 1986; 3/5: 1250-54.
• 21. Lippman SM , Klein EA , Goodman PJ et al.: Efect of selenium and vitamin E on risk of prostate cancer and other cancers. The selenium and vitamin E cancer Prevention Trial (SELECT). JAMA 2009; 301: 39-51.[WoS]
• 22. Goodman GE, Schaffer S, Bankson DD et al.: Predictors of selenium in cigarette smokers and lack of association with lung and prostate cancer risk. Cancer Epidemiology 2001; 10: 1069-76.
• 23. Klein EA , Thompson IM Jr, Tangen CM et al.: Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306: 1549-56.[WoS]
• 24. Jabłońska E, Gromadzińska J, Sobala W et al.: Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr 2008; 47: 47-54.
• 25. Borawska MH, Socha K, Łazarczyk B et al.: The effects of diet on selenium concentration in serum in patients with cancer. Nutrion and Cancer 2009; 61: 629-33.
• 26. Lubiński J, Huzarski T, Byrski T et al.: Adnexectomy status is the feature for association between serum selenium level and the risk of cancer in BRCA1 carriers. Eur J Hum Genet 2010; 18: 192.
• 27. Jaworska K, Durda K, Gupta S et al.: Selenoprotein Genotypes as well as selenium lavels in organisms are critical features of human cancer risk. Wsp Onkol 2011; 15: 39-43.

Identifiers

DOI

10.2478/v10035-012-0080-6